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Badger et al1 demonstrated in their case-control study that
C-reactive protein (CRP) concentration was higher in patients
with abdominal aortic aneurysm (AAA) than that in subjects
without AAA (385.0 L/dL [95% confidence interval, 310.4-
442.8] vs 18.03 L/dL [168.1-196.9]). It has been, however,
controvertible whether higher CRP concentration is associated
with AAA presence. To summarize the present evidence for an
association between CRP and AAA presence, we performed a
meta-analysis of case-control studies that compared CRP con-
centration between patients with AAA and subjects without
AAA.
Our comprehensive search identified six case-control stud-
ies1-6 that compared CRP concentration between patients with
AAA and patients without AAA. In total, our meta-analysis
included data on 744 cases with AAA and 1,288 controls
without AAA. Pooled analysis of the six studies demonstrated
significantly higher CRP concentration in the AAA group than
that in the control group in random-effect models (pooled
standardized mean difference [SMD], 0.50; 95% confidence
interval [CI], 0.09 to 0.91; P .02) (Fig). There was significant
study heterogeneity of results analyzed by means of standard 2
tests (P  .00001) and accordingly a little difference in the
pooled result from fixed-effects modeling (pooled SMD, 0.36;
95% CI, 0.27 to 0.46; P  .00001). Sensitivity analyses were
performed to assess the contribution of each study to the pooled
estimate by excluding individual studies one at a time and
recalculating the pooled SMD estimates for the remaining
studies. Exclusion of the study by Dawson et al3 (pooled SMD,
0.54; 95% CI, 0.08 to 0.99; P  .02), Golledge et al4 (pooled
SMD, 0.60; 95% CI, 0.13 to 1.07; P  .01), Wanhainen et al5
(pooled SMD, 0.60; 95% CI, 0.13 to 1.07; P  .01), or Powell
et al6 (pooled SMD, 0.47; 95% CI, 0.02 to 0.93; P  .04) from
the analysis did not substantively alter the overall result of our
analysis. Meanwhile, eliminating the study by Badger et al1
(pooled SMD, 0.48; 95% CI, –0.11 to 1.07; P .11) or Alberto
et al2 (pooled SMD, 0.30; 95% CI, –0.02 to 0.62; P  .07)
substantially changed the pooled point estimate (no significant
difference between CRP concentration in the AAA and control
group). There was no evidence of significant publication bias
using an adjusted rank-correlation test (P  .0909).
The results of our analysis suggest that CRP concentration in
patients with AAA may be higher than that in patients without
AAA, though several sensitivity analyses substantially changed the
pooled point estimate. Despite the results of the present meta-
analysis and the study by Badger et al,1 however, further studies
may be needed to confirm whether higher CRP concentration is
associated with AAA presence.
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Reply
Thank you for the opportunity to reply to this letter. There is
increasing evidence for the paradigm shift of aneurysm aetiology
from atherosclerosis to inflammatory, although a balance between
the two is likely to reflect reality.1,2 Consequently, an elevation of
C-reactive protein (CRP) is to be expected if this is an accurate
statement.
The inconsistency in the CRP findings by various research-
ers may be due to a number of factors, the first being the
adequacy of study power. The results we obtained, where serum
concentrations of CRP were found to be higher in abdominal
aortic aneurysm (AAA) patients, with a gradation of amount
according to AAA maximal diameter, were based upon a statis-
tically sufficient study participant numbers.3 All but one of the
other studies included less than 100 AAA cases in the study
cohort.4-8 Second, the control selection is variable, ranging
inal aortic aneurysm (AAA) and controls without AAA.bdom
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 1 Letters to the Editor 241from healthy controls to those deemed to be high-risk cardio-
vascular patients.4-8 Clearly, this leads to a bias, since CRP is
recognized as an independent marker of cardiovascular disease.
Although complete control of this co-variable was not possible,
we attempted to account for the presence of ischaemic heart
disease in the study. Third, the analysis of multiple inflammatory
markers concurrently obviously requires statistical compensa-
tion, to avoid a type 1 statistical error. Finally, our study was
mainly to determine the influence of CRP genetic polymor-
phism on serum concentration and aneurysmal disease.3
Nonetheless, we cannot disregard the importance of this
meta-analysis, given the higher level of evidence that it repre-
sents. Therefore, we concur that further research is required to
confirm whether higher CRP concentration is associated with
AAA.
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